Carcinoid syndrome risk factors: Difference between revisions

Jump to navigation Jump to search
 
(One intermediate revision by one other user not shown)
Line 2: Line 2:
{{Carcinoid syndrome}}
{{Carcinoid syndrome}}
{{CMG}}{{AE}}{{PSD}}
{{CMG}}{{AE}}{{PSD}}
==Overiew==
==Overview==
Common [[risk factors]] in the development of [[Carcinoid Syndrome|carcinoid syndrome]] include [[age]] (50 years or older), [[female]] gender, [[Family history (medicine)|family history]] of [[multiple endocrine neoplasia type 1]] and [[neurofibromatosis type 1]], [[atrophic gastritis]], [[pernicious anemia]], and [[Zollinger-Ellison syndrome]].
Common [[risk factors]] in the development of [[Carcinoid Syndrome|carcinoid syndrome]] include [[age]] (50 years or older), [[female]] gender, [[Family history (medicine)|family history]] of [[multiple endocrine neoplasia type 1]] and [[neurofibromatosis type 1]], [[atrophic gastritis]], [[pernicious anemia]], and [[Zollinger-Ellison syndrome]].


Line 8: Line 8:
Common [[risk factors]] in the development of [[Carcinoid Syndrome|carcinoid syndrome]] include:<ref name="risk">Health history can affect the risk of gastrointestinal carcinoid tumors. National Cancer Institute. http://www.cancer.gov/types/gi-carcinoid-tumors/patient/gi-carcinoid-treatment-pdq</ref>  
Common [[risk factors]] in the development of [[Carcinoid Syndrome|carcinoid syndrome]] include:<ref name="risk">Health history can affect the risk of gastrointestinal carcinoid tumors. National Cancer Institute. http://www.cancer.gov/types/gi-carcinoid-tumors/patient/gi-carcinoid-treatment-pdq</ref>  
*Age (50 years or older)
*Age (50 years or older)
*Gende[[Female|r:female]]
*Gender: [[Female|female]]
*Race:[[African Americans]]
*Race:[[African Americans]]
*Family history of [[multiple endocrine neoplasia type 1]]
*Family history of [[multiple endocrine neoplasia type 1]]
Line 16: Line 16:
#[[Von Hippel Lindau syndrome|Von Hippel Lindau disease]]
#[[Von Hippel Lindau syndrome|Von Hippel Lindau disease]]
#[[Familial|Familial small intestinal neuroendocrine tumor]]<ref name="pmid25865046">{{cite journal |vauthors=Sei Y, Zhao X, Forbes J, Szymczak S, Li Q, Trivedi A, Voellinger M, Joy G, Feng J, Whatley M, Jones MS, Harper UL, Marx SJ, Venkatesan AM, Chandrasekharappa SC, Raffeld M, Quezado MM, Louie A, Chen CC, Lim RM, Agarwala R, Schäffer AA, Hughes MS, Bailey-Wilson JE, Wank SA |title=A Hereditary Form of Small Intestinal Carcinoid Associated With a Germline Mutation in Inositol Polyphosphate Multikinase |journal=Gastroenterology |volume=149 |issue=1 |pages=67–78 |date=July 2015 |pmid=25865046 |pmc=4858647 |doi=10.1053/j.gastro.2015.04.008 |url=}}</ref>
#[[Familial|Familial small intestinal neuroendocrine tumor]]<ref name="pmid25865046">{{cite journal |vauthors=Sei Y, Zhao X, Forbes J, Szymczak S, Li Q, Trivedi A, Voellinger M, Joy G, Feng J, Whatley M, Jones MS, Harper UL, Marx SJ, Venkatesan AM, Chandrasekharappa SC, Raffeld M, Quezado MM, Louie A, Chen CC, Lim RM, Agarwala R, Schäffer AA, Hughes MS, Bailey-Wilson JE, Wank SA |title=A Hereditary Form of Small Intestinal Carcinoid Associated With a Germline Mutation in Inositol Polyphosphate Multikinase |journal=Gastroenterology |volume=149 |issue=1 |pages=67–78 |date=July 2015 |pmid=25865046 |pmc=4858647 |doi=10.1053/j.gastro.2015.04.008 |url=}}</ref>
*[[Risk factors]] for [[Carcinoid tumors|carcinoid tumours]] of stomach
*[[Risk factors]] for [[Carcinoid tumors|carcinoid tumours]] of [[stomach]]
#[[Atrophic gastritis]]  
#[[Atrophic gastritis]]  
#[[Pernicious anemia]]
#[[Pernicious anemia]]

Latest revision as of 14:00, 2 April 2021

Carcinoid syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Carcinoid Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Carcinoid syndrome risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Carcinoid syndrome risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Carcinoid syndrome risk factors

CDC on Carcinoid syndrome risk factors

Carcinoid syndrome risk factors in the news

Blogs on Carcinoid syndrome risk factors

Directions to Hospitals Treating Carcinoid syndrome

Risk calculators and risk factors for Carcinoid syndrome risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]

Overview

Common risk factors in the development of carcinoid syndrome include age (50 years or older), female gender, family history of multiple endocrine neoplasia type 1 and neurofibromatosis type 1, atrophic gastritis, pernicious anemia, and Zollinger-Ellison syndrome.

Risk Factors

Common risk factors in the development of carcinoid syndrome include:[1]

  1. Tuberous sclerosis complex
  2. Von Hippel Lindau disease
  3. Familial small intestinal neuroendocrine tumor[2]
  1. Atrophic gastritis
  2. Pernicious anemia
  3. Zollinger-Ellison syndrome

References

  1. Health history can affect the risk of gastrointestinal carcinoid tumors. National Cancer Institute. http://www.cancer.gov/types/gi-carcinoid-tumors/patient/gi-carcinoid-treatment-pdq
  2. Sei Y, Zhao X, Forbes J, Szymczak S, Li Q, Trivedi A, Voellinger M, Joy G, Feng J, Whatley M, Jones MS, Harper UL, Marx SJ, Venkatesan AM, Chandrasekharappa SC, Raffeld M, Quezado MM, Louie A, Chen CC, Lim RM, Agarwala R, Schäffer AA, Hughes MS, Bailey-Wilson JE, Wank SA (July 2015). "A Hereditary Form of Small Intestinal Carcinoid Associated With a Germline Mutation in Inositol Polyphosphate Multikinase". Gastroenterology. 149 (1): 67–78. doi:10.1053/j.gastro.2015.04.008. PMC 4858647. PMID 25865046.

Template:WS Template:WH